Moderate-to-severe Benign Prostatic Hyperplasia (BPH): Clinical Trials

2 trials for Moderate-to-severe Benign Prostatic Hyperplasia (BPH), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Not yet recruiting 1

Follow Moderate-to-severe Benign Prostatic Hyperplasia (BPH): new trials by email Literature Review of Moderate-to-severe Benign Prostatic Hyperplasia (BPH) trials Research Report on Moderate-to-severe Benign Prostatic Hyperplasia (BPH)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions
Test Drug, Reference Drug - Moderate-to-severe Benign Prostatic Hyperplasia (BPH)
Phase 1Not yet recruitingAJU Pharm Co., Ltd.362026-07-012026-06-11
Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions
Test Drug, Reference Drug - Moderate-to-severe Benign Prostatic Hyperplasia (BPH)
Phase 1CompletedAJU Pharm Co., Ltd.452026-06-272026-09-21

Interventions

Drug Evaluation (2)

Sponsors

AJU Pharm Co., Ltd. (2)

Countries

South Korea (2)